COVID‐19 and its effects on the digestive system and endoscopy practice

Abstract The Coronavirus Disease 2019 (COVID‐19) is a respiratory illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and has been classified as a pandemic by the World Health Organization in March 2020. Several studies have demonstrated that the gastrointestinal (GI)...

Full description

Bibliographic Details
Main Authors: Enrik John T. Aguila, Ian Homer Y. Cua, Joseph Erwin L. Dumagpi, Carlos Paolo D. Francisco, Nikko Theodore V. Raymundo, Marianne Linley L. Sy‐Janairo, Patricia Anne I. Cabral‐Prodigalidad, Marie Antoinette DC. Lontok
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:JGH Open
Subjects:
Online Access:https://doi.org/10.1002/jgh3.12358
id doaj-a1805d5a417f4a8ab50ef6ad9b47342b
record_format Article
spelling doaj-a1805d5a417f4a8ab50ef6ad9b47342b2021-05-02T18:37:30ZengWileyJGH Open2397-90702020-06-014332433110.1002/jgh3.12358COVID‐19 and its effects on the digestive system and endoscopy practiceEnrik John T. Aguila0Ian Homer Y. Cua1Joseph Erwin L. Dumagpi2Carlos Paolo D. Francisco3Nikko Theodore V. Raymundo4Marianne Linley L. Sy‐Janairo5Patricia Anne I. Cabral‐Prodigalidad6Marie Antoinette DC. Lontok7Institute of Digestive and Liver Diseases St. Luke's Medical Center ‐ Global City PhilippinesInstitute of Digestive and Liver Diseases St. Luke's Medical Center ‐ Global City PhilippinesInstitute of Digestive and Liver Diseases St. Luke's Medical Center ‐ Global City PhilippinesInstitute of Digestive and Liver Diseases St. Luke's Medical Center ‐ Global City PhilippinesInstitute of Digestive and Liver Diseases St. Luke's Medical Center ‐ Global City PhilippinesInstitute of Digestive and Liver Diseases St. Luke's Medical Center ‐ Global City PhilippinesInstitute of Digestive and Liver Diseases St. Luke's Medical Center ‐ Global City PhilippinesInstitute of Digestive and Liver Diseases St. Luke's Medical Center ‐ Global City PhilippinesAbstract The Coronavirus Disease 2019 (COVID‐19) is a respiratory illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and has been classified as a pandemic by the World Health Organization in March 2020. Several studies have demonstrated that the gastrointestinal (GI) tract is also a potential route. As the pandemic is continuously evolving, and more data are made available, this article highlights the best evidence and practices regarding the effects of the SARS‐CoV‐2 virus relevant to GI practice. Published clinical studies have supported that SARS‐CoV‐2 affects the GI tract and the liver. The largest published dataset comprised of 4243 patients and showed a pooled prevalence of GI symptoms at 17.6%. GI symptoms varied and usually preceded pulmonary symptoms by 1–2 days. These include anorexia (26.8%), nausea and vomiting (10.2%), diarrhea (12.5%), and abdominal pain (9.2%). Incidence of liver injury ranges from 15 to 53%. Evidence shows that the severity of COVID‐19 infection is compounded by its effects on nutrition, most especially for the critically ill. As such, nutrition societies have recommended optimization of oral diets and oral nutritional supplements followed by early enteral nutrition if nutritional targets are not met, and parenteral nutrition in the distal end of the spectrum. In addition to possible fecal–oral transmission, GI endoscopy procedures, which are considered to be aerosol‐generating procedures, contribute to increased risk to GI health‐care professionals. Infection prevention measures and guidelines are essential in protecting both patients and personnel.https://doi.org/10.1002/jgh3.12358COVID‐19endoscopygastroenterologylivernutrition
collection DOAJ
language English
format Article
sources DOAJ
author Enrik John T. Aguila
Ian Homer Y. Cua
Joseph Erwin L. Dumagpi
Carlos Paolo D. Francisco
Nikko Theodore V. Raymundo
Marianne Linley L. Sy‐Janairo
Patricia Anne I. Cabral‐Prodigalidad
Marie Antoinette DC. Lontok
spellingShingle Enrik John T. Aguila
Ian Homer Y. Cua
Joseph Erwin L. Dumagpi
Carlos Paolo D. Francisco
Nikko Theodore V. Raymundo
Marianne Linley L. Sy‐Janairo
Patricia Anne I. Cabral‐Prodigalidad
Marie Antoinette DC. Lontok
COVID‐19 and its effects on the digestive system and endoscopy practice
JGH Open
COVID‐19
endoscopy
gastroenterology
liver
nutrition
author_facet Enrik John T. Aguila
Ian Homer Y. Cua
Joseph Erwin L. Dumagpi
Carlos Paolo D. Francisco
Nikko Theodore V. Raymundo
Marianne Linley L. Sy‐Janairo
Patricia Anne I. Cabral‐Prodigalidad
Marie Antoinette DC. Lontok
author_sort Enrik John T. Aguila
title COVID‐19 and its effects on the digestive system and endoscopy practice
title_short COVID‐19 and its effects on the digestive system and endoscopy practice
title_full COVID‐19 and its effects on the digestive system and endoscopy practice
title_fullStr COVID‐19 and its effects on the digestive system and endoscopy practice
title_full_unstemmed COVID‐19 and its effects on the digestive system and endoscopy practice
title_sort covid‐19 and its effects on the digestive system and endoscopy practice
publisher Wiley
series JGH Open
issn 2397-9070
publishDate 2020-06-01
description Abstract The Coronavirus Disease 2019 (COVID‐19) is a respiratory illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and has been classified as a pandemic by the World Health Organization in March 2020. Several studies have demonstrated that the gastrointestinal (GI) tract is also a potential route. As the pandemic is continuously evolving, and more data are made available, this article highlights the best evidence and practices regarding the effects of the SARS‐CoV‐2 virus relevant to GI practice. Published clinical studies have supported that SARS‐CoV‐2 affects the GI tract and the liver. The largest published dataset comprised of 4243 patients and showed a pooled prevalence of GI symptoms at 17.6%. GI symptoms varied and usually preceded pulmonary symptoms by 1–2 days. These include anorexia (26.8%), nausea and vomiting (10.2%), diarrhea (12.5%), and abdominal pain (9.2%). Incidence of liver injury ranges from 15 to 53%. Evidence shows that the severity of COVID‐19 infection is compounded by its effects on nutrition, most especially for the critically ill. As such, nutrition societies have recommended optimization of oral diets and oral nutritional supplements followed by early enteral nutrition if nutritional targets are not met, and parenteral nutrition in the distal end of the spectrum. In addition to possible fecal–oral transmission, GI endoscopy procedures, which are considered to be aerosol‐generating procedures, contribute to increased risk to GI health‐care professionals. Infection prevention measures and guidelines are essential in protecting both patients and personnel.
topic COVID‐19
endoscopy
gastroenterology
liver
nutrition
url https://doi.org/10.1002/jgh3.12358
work_keys_str_mv AT enrikjohntaguila covid19anditseffectsonthedigestivesystemandendoscopypractice
AT ianhomerycua covid19anditseffectsonthedigestivesystemandendoscopypractice
AT josepherwinldumagpi covid19anditseffectsonthedigestivesystemandendoscopypractice
AT carlospaolodfrancisco covid19anditseffectsonthedigestivesystemandendoscopypractice
AT nikkotheodorevraymundo covid19anditseffectsonthedigestivesystemandendoscopypractice
AT mariannelinleylsyjanairo covid19anditseffectsonthedigestivesystemandendoscopypractice
AT patriciaanneicabralprodigalidad covid19anditseffectsonthedigestivesystemandendoscopypractice
AT marieantoinettedclontok covid19anditseffectsonthedigestivesystemandendoscopypractice
_version_ 1721488787999031296